{
    "title": "Teva raises 2014 profit forecast after strong third quarter",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2814409/Teva-raises-2014-profit-forecast-strong-quarter.html",
    "date": "2014-10-30",
    "keywords": [
        "teva",
        "copaxone",
        "drug",
        "share",
        "percent",
        "quarter",
        "patent",
        "competition",
        "profitability",
        "protection",
        "inc",
        "company",
        "profit",
        "forecast",
        "october",
        "gmt",
        "vigodman",
        "court",
        "year",
        "week",
        "track",
        "revenue",
        "email",
        "cohentel",
        "aviv",
        "thirdquarter",
        "hopeful",
        "drugmaker",
        "outlook",
        "estimate",
        "executive",
        "erez",
        "favour",
        "decision",
        "month",
        "fight",
        "september",
        "novartis",
        "momenta",
        "mylan",
        "pharma",
        "ltdteva",
        "formulation",
        "yearendturnaroundteva",
        "brought",
        "turnaround",
        "specialist",
        "business",
        "conference",
        "call",
        "cost",
        "process",
        "drive",
        "franchise",
        "analyst",
        "marc",
        "upside",
        "stock",
        "goodman",
        "rating",
        "york",
        "trade",
        "high",
        "yearteva",
        "billionteva",
        "thomson",
        "introduction",
        "income",
        "monthteva",
        "repurchase",
        "programme",
        "dividend",
        "repotring",
        "scheer",
        "editing",
        "william",
        "hardy",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}